MedPath

SANDOZ MIRTAZAPINE

SANDOZ MIRTAZAPINE

Approved
DIN Number

02250608

Drug Class

Human

Market Date

Mar 31, 2004

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02250608
AIG Number0143928002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX11 MIRTAZAPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIRTAZAPINEActive
Strength: 30 MG
Monograph: MIRTAZAPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.